All Cancer Microbiology articles
-
NewsEurope backs first cervical cancer vaccination campaign in Angola
Angola’s first national vaccination campaign will immunise over 2 million girls aged 9–12 against cervical cancer. The national rollout began this week with coordinated delivery across schools, clinics, and communities in all 21 provinces.
-
NewsLighting up life: scientists develop glowing sensors to track cellular changes as they happen
Researchers have engineered living cells to use a 21st amino acid that illuminates protein changes in real time, providing a new method for observing changes within cells. The technique is effective in bacteria, human cells and live tumor models, making it possible to study complex diseases like cancer more ethically.
-
NewsReview explores roles, mechanisms and applications of intra-tumoral microbiota in cancers
A recent review provides an overview of the hallmarks, roles, molecular mechanisms, and clinical applications of intra-tumoral microbiota in multiple human cancers.
-
NewsNew platform for the production of versatile active ingredients
With the help of a newly developed chemo-enzymatic platform, researchers have succeeded in producing a large number of different furanolides in larger quantities and characterizing their biological activity.
-
NewsStudy finds COVID-19 mRNA vaccine sparks immune response to fight cancer
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
-
NewsStudy reveals how bacteria in tumors drive treatment resistance in cancer
Researchers have uncovered a previously unknown way for microbes within tumors to contribute to treatment resistance in certain cancers. The study finds these microbes push cancer cells into a reversible resting state, allowing them to become resistant to certain chemotherapies.
-
NewsSafer, more effective vaccines with new mRNA vaccine technology
A new messenger ribonucleic acid (mRNA) vaccine technology could make future vaccines safer, more effective, and less burdensome for patients. The new approach uses albumin-recruiting lipid nanoparticles to deliver mRNA precisely to lymph nodes while bypassing the liver.
-
NewsScientists research potential anti-ulcer vaccine targeting Helicobacter pylori
Scientists are on the way to finding a vaccine to fight off the Helicobacter pylori bacterium, possibly preventing stomach ulcers and lowering the risk for stomach cancer. They used immunoinformatics to scan its genetic makeup and predict which parts can trigger a strong immune response.
-
NewsEngineered bacterial therapy activates immune response in cancer preclinical studies
Researchers have developed a new bacterial immunotherapy that delivers immune-activating proteins directly to solid tumors, which can often suppress the immune system. ACTM-838 targets phagocytic immune cells within the tumor microenvironment.
-
NewsChanges in gut microbiota influence which patients get AIG-related neuroendocrine tumors
Researchers have discovered how the balance of bacteria in the stomach affects the growth of neuroendocrine tumors (NETs). By identifying the specific bacteria involved and the biochemical reactions that cause tumor growth, they hope to detect which patients are most likely to develop cancer.
-
NewsMicroplastics found to change gut microbiome in first human-sample study
New research presented today at UEG Week 2025 shows that microplastics can alter the human gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer.
-
NewsGenetic ‘Trojan horse’ selectively kills cancer cells linked to Kaposi’s sarcoma
A highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus harnesses an adeno-associated virus (AAV) to deliver a genetic “Trojan horse” into infected cells.
-
NewsNew herpes virus–based vaccine could cure cancer in the future without side effects
The Herpes simplex virus is a widespread virus that often causes cold sores, and most people carry it. By removing a virulence gene, i.e. a gene that makes the virus harmful to humans, the herpes virus can be repurposed as a cancer vaccine.
-
NewsNew one-hour, low-cost HPV test could transform cervical cancer screening in Africa and beyond
A team of researchers has developed a simple, affordable human papillomavirus (HPV) test that delivers results in less than an hour with no specialized laboratory required.
-
NewsStudy shows HPV vaccine protects vaccinated — and unvaccinated — women
A study has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from infections caused by the cervical-cancer-causing virus—including women who didn’t even receive the vaccine.
-
NewsNew study supports gene-tailored radiation doses to treat HPV+ throat cancer
Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according to a new study that builds on a growing body of evidence that radiation treatment can be personalized using tumor genomics.
-
NewsFatty acids feed cancer-promoting bacteria: How chronic cellular stress alters the gut microbiome
Researchers have identified a cellular mechanism that alters the gut microbiome in a way that promotes cancer. An analysis of patient data shows that the findings also apply to humans.
-
NewsEngineered gut bacteria improves survival outcomes in colorectal cancer tumors
A genetically modified Salmonella typhimurium strain can colonise tumours and release a therapeutic protein, LIGHT, to induce the formation of mature tertiary lymphoid structures (mTLSs) in laboratory models.
-
NewsMolecular roadmap links stomach infection to cancer risk
A new study has identified protein signatures that trace the trajectory from Helicobacter pylori infection to the progression of gastric lesions and eventual cancer. Researchers pinpointed 28 proteins that change consistently during this process.
-
NewsResearch breakthrough offers hope for new colorectal cancer treatments
Researchers have identified the key mechanism by which Fusobacterium nucleatum binds to the human cell receptors CEACAM1 and CEACAM5, which are frequently overexpressed on many types of cancer cells.